13F HOLDINGS REPORT
Foresite Capital Management V, LLC
Quarter ended Q3 2023 · Filed August 11, 2023 · Accession 0001104659-23-090058
Total Value
$136.9M
Positions
10
Other Managers
0
Confidential Omitted
No
Holdings (10)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Hims & Hers Health, Inc. | HIMS | 3,733,381 | $35.1M | 25.63% |
| 2 | Theseus Pharmaceuticals, Inc. | 88369M101 | 3,585,346 | $33.5M | 24.43% |
| 3 | Pardes Biosciences Inc | 69945Q105 | 10,811,887 | $19.6M | 14.29% |
| 4 | Aclaris Therapeutics, Inc. | ACRS | 1,258,243 | $13.0M | 9.53% |
| 5 | Disc Medicine, Inc. | IRON | 243,513 | $10.8M | 7.90% |
| 6 | Kinnate Biopharma Inc. | 49705R105 | 3,525,957 | $10.7M | 7.80% |
| 7 | Somalogic, Inc. | 83444K105 | 3,403,276 | $7.9M | 5.74% |
| 8 | Compass Therapeutics, Inc. | CMPX | 1,324,071 | $4.2M | 3.08% |
| 9 | Quantum Si Inc | QSIAW | 924,404 | $1.7M | 1.21% |
| 10 | Pharvaris N.V. | PHVS | 34,142 | $516,910 | 0.38% |